Pustulose exanthématique aiguë généralisée induite par le phloroglucinol (Spasfon ® )

Brahimi, N.; Maubec, Ève; Petit, Thomas; Crickx, B; Descamps, V.

doi:10.1016/j.annder.2017.01.009

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Citation Types

Supporting

Mentioning

Contrasting

Unclassified

Year Published

2017

2024

Publication Types

Select...

Article6

Relationship

Self Cite0

Independent6

Authors

Journals

Cited by 6 publications

(1 citation statement)

References 6 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Nous décrivons probablement le premier cas de PEAG imputable au phloroglucinol au Cameroun et le deuxième cas connu à ce jour [5]. La PEAG est une toxidermie rare, parfois grave, avec une prédilection féminine [6].…”

Section: Discussionunclassified

Paederus dermatitis: Clinical and epidemiological characteristics of 104 new cases collected at the University Hospital of Conakry, Guinea

Kouotou¹,

Maffo²

2022

Our Dermatol Online

View full text Add to dashboard Cite

Described for the first time in 1980 by BEYLOT et al, acute generalized exanthematous pustulosis (AGEP) is a rare and serious condition characterized by the sudden onset of a pustular and scarlatiniform febrile rash. In more than 90% of cases it is caused by medication, but can also be caused by a virus (enterovirus infection: coxsackie, echovirus or cytomegalovirus), a toxic agent (mercury) or a food allergen. The evolution of AGEP is usually favourable to the discontinuation of the drug in question with a delay varying from 48 hours to 15 days. We report a case of AGEP for which the drug responsible was not one of the drugs classically incriminated.

show abstract

Section: Discussionunclassified